AI assistant
Sending…
NeuroPace Inc — Director's Dealing 2026
Feb 23, 2026
33194_dirs_2026-02-23_fef1f593-632c-40f7-9f63-f496583d6fbd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NeuroPace Inc (NPCE)
CIK: 0001528287
Period of Report: 2026-02-20
Reporting Person: Morrell Martha (CHIEF MEDICAL OFFICER)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-02-20 | Common Stock | F | 3412 | $14.34 | Disposed | 75322 | Direct |
Footnotes
F1: Represents the number of shares withheld by the Issuer on February 20, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award.
More from NeuroPace Inc
Regulatory Filings
2026
May 12
Proxy Solicitation & Information Statement
2026
Apr 21
Director's Dealing
2026
Mar 24
Director's Dealing
2026
Mar 24
Director's Dealing
2026
Mar 4
Annual Report
2026
Mar 3
Regulatory Filings
2026
Mar 3
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Director's Dealing
2025
Dec 23